Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,835,954
-$242,728 QoQ
Shares Held
123,237
-7.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#579
of 3,769 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COLDSTREAM CAPITAL MANAGEMENT INC holds $126,380,504 across 14 Drug Manufacturers - General names. MRK ranks #4 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
36,385 | $43,641,264 | |
| 2 | JNJ |
Johnson & Johnson
|
92,571 | $23,510,256 | |
| 3 | ABBV |
AbbVie Inc.
|
73,209 | $18,422,312 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
123,237 | $15,835,954 | |
| 5 | AMGN |
Amgen Inc
|
19,733 | $7,145,713 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
35,562 | $4,492,903 | |
| 7 | NVS |
Novartis AG
|
17,467 | $2,737,428 | |
| 8 | PFE |
Pfizer Inc
|
110,237 | $2,654,506 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,835,954 | 123,237 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,078,682 | 133,666 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $12,825,087 | 121,842 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $10,354,108 | 123,366 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $8,662,162 | 109,426 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $9,276,696 | 103,350 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $11,042,777 | 111,005 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,628,430 | 102,399 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $11,743,049 | 94,855 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $12,455,816 | 94,398 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,942,733 | 91,201 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $8,996,594 | 87,388 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $9,150,311 | 79,299 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $8,688,552 | 81,667 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,048,194 | 81,552 | Shares | Sole | 2023-01-10 | |
| 2022-06-30 | $7,982,024 | 87,551 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $6,695,033 | 81,597 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $6,105,065 | 79,659 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,928,328 | 52,301 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,709,595 | 60,558 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,719,837 | 61,225 | Shares | Sole | 2021-06-16 | |
| 2020-12-31 | $4,820,144 | 58,926 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,937,970 | 47,474 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,644,487 | 47,129 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,710,583 | 48,227 | Shares | Sole | 2020-05-27 | |
| No filing history on record for this holder in this stock. | ||||||